How much does Ocrevus cost?

Ocrevus costs approximately $20,769 for one 300 mg/10mL vial depending on the pharmacy you visit and based on using the Drugs.com discount card. This price is for cash paying customers and is not valid with insurance plans. Most people do not pay for the full cost of Ocrevus.

Related: Drugs.com Pricing, Online Coupons and Manufacturer’s Savings

• Ocrevus Price Guide

Without insurance or additional assistance, this would work out to an annual cost of just over $83,000 per year. This is because Ocrevus is given initially as 2 separate infusions of 300 mg, 2 weeks apart. Then 1 infusion of 600 mg every 6 months.

People with commercial or private insurance may be eligible for Ocrevus Co-Pay assistance and pay as little as $0 per infusion. Co-pay assistance is provided up to $1,500 per calendar year in the first year and up to $1,000 each calendar year after.

If you have Medicare your cost for a year of Ocrevus may range between $0 and $15,772. Almost half of people with Medicare pay $0.

If you have Medicaid your cost for a year of Ocrevus may be minimal but the specific amount depends on your income level and state regulations.

If you are unable to afford Ocrevus, you may be able to apply for additional assistance through the Genentech Patient Foundation. The foundation provides Ocrevus for free to people who have been prescribed this medicine and don’t have insurance or who have financial concerns and meet certain eligibility criteria.

There may be additional costs associated with the administration of Ocrevus, depending on your health care provider and the location of the infusion.

Related questions

• What are monoclonal antibodies?
• Is Kesimpta better than Ocrevus?
• Briumvi vs Ocrevus: How do they compare?

How many Ocrevus infusions do you need and how often do you need them?

The initial dose of Ocrevus is 300mg given by IV infusion via Ocrevus IV solution diluted into an infusion bag containing 0.9% sodium chloride and given directly into a vein over at least 2.5 hours. This is followed two weeks later by a second 300mg infusion.

After those first two doses, the recommended dosage is a single 600mg infusion given once every six months by your health care provider. This infusion should be infused over two hours for those who have not experienced any prior serious infusion reactions (IRs), or over at least 3.5 hours for those who have experienced serious IRs in the past.